VUB - MICROFLOW CELL
Company description |
Background |
The µFlow Cell valorizes the R&D of a consortium between the µFlow Group of prof. Wim De Malsche of the Department of Chemical Engineering (CHIS) and Department of Bioengineering Sciences (DBIT) and prof. Karine Hellemans of the Diabetes Pathology and Therapy (DIAB) of the Free University of Brussels (VUB). The research activities of the multidisciplinary team of more than 20 have led to 1 spin-off, 10 patents, and more than 30 collaborative projects funded by industry, and local, national and European funding agencies. |
Highlights |
The µFlow Cell is focused on medical, pharmaceutical and biotech applications, and aspires cooperation with industry along three routes:
|
Expertise |
The µFlow Cell has a dedicated team of experts and technicians with access to an internal polymer workshop as well as a new cleanroom for advanced microfabrication of silicon and glass. The expertise of the consortium is focused on the following research lines:
|
Microlab |
VUB is building a new class 100 cleanroom for advanced microfabrication of microfluidic devices in glass and silicon. This Core Facility is expected to be operational by the end of 2022 and will be managed by the µFlow Cell as an open access facility where research groups and industry will get access against a usage fee. |
Contact details* | |
Filip LegeinValorization Manager |
* You will only be able to send meeting requests to exhibitors/participants that registered for the same virtual matchmaking sessions as you, sign up for matchmaking sessions in your account if this exhibitor is not available.